+

WO2007002666A3 - Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant - Google Patents

Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant Download PDF

Info

Publication number
WO2007002666A3
WO2007002666A3 PCT/US2006/024968 US2006024968W WO2007002666A3 WO 2007002666 A3 WO2007002666 A3 WO 2007002666A3 US 2006024968 W US2006024968 W US 2006024968W WO 2007002666 A3 WO2007002666 A3 WO 2007002666A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical
plant
therapeutic
derived
novel
Prior art date
Application number
PCT/US2006/024968
Other languages
French (fr)
Other versions
WO2007002666A2 (en
Inventor
Alex Moffett
Parag Shah
Original Assignee
Renaissance Herbs Inc
Alex Moffett
Parag Shah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/281,302 external-priority patent/US20060105069A1/en
Application filed by Renaissance Herbs Inc, Alex Moffett, Parag Shah filed Critical Renaissance Herbs Inc
Publication of WO2007002666A2 publication Critical patent/WO2007002666A2/en
Publication of WO2007002666A3 publication Critical patent/WO2007002666A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to pharmaceutical, therapeutic, nutritional, cosmetic, and dermatological compositions derived from the preicarp (rind) of the Garcinia mangostana L plant and the novel extraction processes used to produce those compositions. Specifically, the present invention relates, in part, to an approximately 0.01% to about 80% mixture of a xanthone-rich mangosteen pericarp (rind) extract in novel combinations for pharmaceutical, cosmetic, therapeutic or dermatological compositions that yield surprising health benefits. Additionally, the present invention relates, in part, to novel extraction processes that result in the production of the novel compositions of the invention.
PCT/US2006/024968 2005-06-22 2006-06-22 Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant WO2007002666A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US69285405P 2005-06-22 2005-06-22
US60/692,854 2005-06-22
US11/281,302 US20060105069A1 (en) 2004-11-16 2005-11-16 Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant
IN1668CH2005 2005-11-16
IN1668/CHE/2005 2005-11-16
US11/281,302 2005-11-16

Publications (2)

Publication Number Publication Date
WO2007002666A2 WO2007002666A2 (en) 2007-01-04
WO2007002666A3 true WO2007002666A3 (en) 2007-07-12

Family

ID=37595980

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/024968 WO2007002666A2 (en) 2005-06-22 2006-06-22 Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant

Country Status (1)

Country Link
WO (1) WO2007002666A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080187502A1 (en) 2007-02-02 2008-08-07 Michelle Garay Assessment and mitigation of oxidative stress in skin
FR2917621B1 (en) * 2007-06-20 2009-09-18 Centre Nat Rech Scient USE OF OXYGENIC HETEROCYCLES SELECTED AMONG XANTHONES AND BIFLAVONOIDS FOR THE PREPARATION OF A COMPOSITION INTENDED TO ACT AS AN ANTI-COCCIDIAN AGENT
WO2009093255A2 (en) 2008-01-21 2009-07-30 Ganga Raju Gokaraju A new nutraceutical composition from garcinia mangostana
ITMI20130619A1 (en) * 2013-04-16 2014-10-17 Variati S R L NEW COSMETIC ASSOCIATION
CN103393576B (en) * 2013-08-07 2015-12-23 伽蓝（集团）股份有限公司 A kind of mangosteen extract and application thereof
CN106361784B (en) * 2015-07-24 2020-08-14 山酮新药开发股份有限公司 Use of mangosteen husk extract for the treatment of skin diseases
CN105168478A (en) * 2015-08-28 2015-12-23 无限极（中国）有限公司 Skin care product and preparation method thereof
KR102160798B1 (en) * 2017-05-23 2020-09-29 동국대학교 산학협력단 Composition comprising extract of Garcinia Mangostana or xanthone compounds derived from for treating or preventing porcine epidemic diarrhea
US20210353701A1 (en) * 2018-11-02 2021-11-18 Shiseido Company, Ltd. Ultraviolet light-induced inflammation suppressing agent comprising alternative autophagy inducing agent
CN113816936B (en) * 2020-06-19 2023-05-02 广州长峰生物技术有限公司 Mangostin derivative compound and preparation method and application thereof
CN113620967B (en) * 2021-07-31 2023-01-06 广州中医药大学(广州中医药研究院) Alpha-mangostin derivative and preparation method and application thereof
CN113717144B (en) * 2021-09-24 2023-04-11 湖南朗林生物资源股份有限公司 Method for extracting alpha-mangostin and gamma-mangostin from mangosteen
WO2023077397A1 (en) * 2021-11-05 2023-05-11 Xantho Biotechnology Co., Ltd Use of mangosteen fruit shell extract in the preparation of a medicament for treating psoriasis
FR3134313B1 (en) * 2022-04-07 2024-04-05 Fabre Pierre Dermo Cosmetique Combination of a Garcinia mangostana extract and fresh Avena sativa juice to fight against inflammation induced by C. acnes

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306486A (en) * 1993-03-01 1994-04-26 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic sunscreen composition containing green tea and a sunscreen
US20030138467A1 (en) * 2001-12-27 2003-07-24 Avon Products, Inc. Methods for improving the aesthetic appearance of skin
US20030175237A1 (en) * 2002-02-26 2003-09-18 Bailey William L. Method for the reduction of fasting plasma glucose and hemoglobin AIC levels

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306486A (en) * 1993-03-01 1994-04-26 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic sunscreen composition containing green tea and a sunscreen
US20030138467A1 (en) * 2001-12-27 2003-07-24 Avon Products, Inc. Methods for improving the aesthetic appearance of skin
US20030175237A1 (en) * 2002-02-26 2003-09-18 Bailey William L. Method for the reduction of fasting plasma glucose and hemoglobin AIC levels

Also Published As

Publication number Publication date
WO2007002666A2 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
WO2007002666A3 (en) Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant
WO2007067495A3 (en) Levodopa prodrug mesylate, compositions thereof, and uses thereof
WO2007109210A3 (en) Extracts and methods comprising curcuma species
WO2006099169A3 (en) Novel liposome compositions
MY142017A (en) Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
WO2004035629A8 (en) Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
WO2005046575A3 (en) Amino acid prodrugs
MX2009011869A (en) Liquorice extract antimicrobial and anti-inflammatory isolates.
WO2009019534A3 (en) Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
WO2008148873A3 (en) Hydroxyproline compositions and uses thereof
WO2008030818A3 (en) Novel liposome compositions
WO2006034154A3 (en) Salts of 5-azacytidine
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
PT1594833E (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
WO2006078699A3 (en) Oral care compositions derived from the labiatae family
SG114627A1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
WO2007113291A3 (en) Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same
GEP20115332B (en) Herbal composition for inflammatory disorders
WO2007048398A3 (en) Preparation and use of a phytotherapeutic agent
ATE452120T1 (en) FATTY ACID BENZENEDIOL DERIVATIVES AND PRODUCTION AND USE PROCESSES THEREOF
MX2011008261A (en) Pharmaceutical compositions comprising tgf- î²1 inhibitor peptides.
WO2004033448A3 (en) Isolation, purification and synthesis of procyanidin b2 and uses thereof
WO2008135661A3 (en) Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
CY1110401T1 (en) PRODUCTION OF 1-PHENYLCOCARCAROXYLIC ACIDS FOR TREATMENT OF NEUROCOLOGICAL DISEASES
WO2007083006A3 (en) Use of an unsaponifiable extract of plant pulp in the treatment of skin ageing

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06774096

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载